Recombinant Danio rerio Prepro-urotensin II-beta (uts2b)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Danio rerio Prepro-urotensin II-beta (uts2b)

Recombinant Danio rerio Prepro-urotensin II-beta (uts2b) is a recombinant protein derived from zebrafish, a species widely used in biomedical research due to its genetic similarity to humans and its rapid breeding cycle. This protein is part of the urotensin II family, which plays significant roles in cardiovascular function, inflammation, and potentially in the development of spinal morphology.

Background on Urotensin II and Related Peptides

Urotensin II is a cyclic peptide originally identified in fish but later found in mammals as well. It signals through G-protein-coupled receptors and has been linked to cardiovascular diseases and other physiological processes. In zebrafish, urotensin II-related peptides like Urp1 and Urp2 have been shown to influence spine morphology by maintaining its structure and preventing abnormal curvatures during growth .

Characteristics of Recombinant Danio rerio Prepro-urotensin II-beta (uts2b)

The recombinant Danio rerio Prepro-urotensin II-beta (uts2b) protein is available in various expression systems, including yeast, E. coli, baculovirus, and mammalian cells . This diversity in expression systems allows researchers to choose the most suitable form for their specific applications, whether it be for biochemical assays, structural studies, or functional analyses.

Expression Systems and Features:

Expression SystemSourceFeatures
YeastCSB-YP801894DILSuitable for large-scale production
E. coliCSB-EP801894DILCost-effective, high yield
E. coli (Biotinylated)CSB-EP801894DIL-BAvi-tag biotinylated for specific binding assays
BaculovirusCSB-BP801894DILHigh expression levels in insect cells
Mammalian cellCSB-MP801894DILNative-like post-translational modifications

Future Directions

Future studies on Recombinant Danio rerio Prepro-urotensin II-beta (uts2b) could explore its signaling pathways and interactions with other proteins involved in spinal development. Additionally, comparing its function across different species could provide insights into evolutionary conservation and potential therapeutic targets.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
uts2bPrepro-urotensin II-beta [Cleaved into: Urophysin beta; Urotensin II-beta; U-II-beta; UII-beta)]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
22-106
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Danio rerio (Zebrafish) (Brachydanio rerio)
Target Names
uts2b
Target Protein Sequence
HPVVQSAEM SFGRPVVVEE EQALNPEELS FSEQAYLSHD AAGFGYPSLI SGDISSDGLR TAGFVPSQAV KEALLEKPLW SRFLGS
Uniprot No.

Target Background

Function
Urotensin is found in the teleost caudal neurosecretory system. It is implicated in osmoregulation and as a corticotropin-releasing factor.
Gene References Into Functions
  1. This study details the distribution of urotensin I, UIIα, and UIIβ mRNAs in various organs, along with their cellular localization in the spinal cord, as determined by in situ hybridization (ISH) histochemistry. PMID: 18403048
Database Links

KEGG: dre:402853

UniGene: Dr.24977

Protein Families
Urotensin-2 family
Subcellular Location
Secreted.

Q&A

What are the recommended storage conditions for maintaining uts2b stability?

The stability and shelf life of recombinant uts2b depend on several factors including storage state, buffer ingredients, and storage temperature. For optimal preservation of protein integrity, the following guidelines should be followed:

FormStorage TemperatureShelf LifeNotes
Liquid-20°C/-80°C6 monthsAvoid repeated freeze-thaw cycles
Lyophilized-20°C/-80°C12 monthsPreferred for long-term storage
Working aliquots4°CUp to one weekFor immediate use

Repeated freezing and thawing should be avoided as it can lead to protein degradation and loss of activity . It is advisable to prepare small working aliquots that can be stored at 4°C for up to one week to minimize freeze-thaw cycles while maintaining experimental consistency .

How should recombinant uts2b be reconstituted for experimental use?

For proper reconstitution of uts2b, follow this methodological approach:

  • Briefly centrifuge the vial prior to opening to bring the contents to the bottom

  • Reconstitute the protein in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% (50% is the standard recommendation)

  • Prepare small aliquots for long-term storage at -20°C/-80°C

This protocol minimizes protein denaturation while ensuring sample homogeneity . The addition of glycerol serves as a cryoprotectant that helps maintain protein structure during freezing and thawing processes. When designing experiments, it is important to consider the potential effects of glycerol on your experimental system, especially for functional assays where buffer components may influence outcomes.

What quality control measures verify the identity and integrity of recombinant uts2b?

Several analytical techniques should be employed to verify the identity and integrity of recombinant uts2b:

  • SDS-PAGE Analysis: Confirms the molecular weight and purity (>85% for commercial preparations)

  • Western Blotting: Verifies protein identity using specific antibodies

  • Mass Spectrometry: Provides precise molecular weight confirmation and can detect post-translational modifications

  • Sequence Verification: N-terminal sequencing confirms the correct processing of the mature protein

  • Functional Assays: Activity tests specific to urotensin II signaling pathways

These quality control measures ensure experimental reproducibility and valid research outcomes. For collaborative projects or publication purposes, it is advisable to document these verification steps to strengthen the reliability of your findings.

How does zebrafish uts2b compare to urotensin II proteins in other species?

Zebrafish uts2b (Prepro-urotensin II-beta) represents one of the evolutionary variants of the urotensin II system found in teleost fish. When conducting comparative studies, researchers should note:

SpeciesProtein FeaturesSequence HomologyFunctional Conservation
Zebrafish (Danio rerio)Two paralogs: uts2a and uts2bReferenceDual system with potentially divergent functions
HumanSingle UTS2 geneModerate conservation in mature peptidePotent vasoactive peptide
Mouse/RatSingle Uts2 geneModerate conservationModel organism for mammalian studies
Other teleostsOften multiple paralogsVariableSpecies-specific adaptations

Cross-species research requires careful consideration of these evolutionary differences when interpreting experimental results and designing functional assays . The presence of two paralogs in zebrafish (uts2a and uts2b) may indicate subfunctionalization or neofunctionalization following the teleost-specific genome duplication event, creating unique research opportunities for studying the evolution of peptide hormone systems.

How can perturbation experiments be designed to study uts2b function in zebrafish development?

Designing effective perturbation experiments to study uts2b function requires a systematic approach:

  • Genetic Perturbation Methods:

    • CRISPR/Cas9 knockout: Design guide RNAs targeting uts2b exons

    • Morpholino knockdown: Target splice junctions or translation start sites

    • Overexpression: Inject mRNA encoding full-length or processed uts2b forms

  • Experimental Controls:

    • Include both positive controls (known phenotypes) and negative controls (non-targeting interventions)

    • Use paralog-specific interventions to distinguish between uts2a and uts2b functions

    • Implement rescue experiments to confirm specificity

  • Phenotypic Analysis Pipeline:

    • Temporal assessment: Examine effects at multiple developmental stages

    • Spatial analysis: Perform in situ hybridization to detect expression changes

    • Functional readouts: Measure physiological parameters (heart rate, vascular development)

  • Molecular Profiling:

    • Perform RNA-seq to identify differentially expressed genes

    • Use phosphoproteomics to detect signaling pathway alterations

    • Implement ChIP-seq to identify downstream transcriptional effects

These perturbation experiments should be designed with appropriate statistical power to detect biologically relevant effects while minimizing false discoveries . The analysis should account for both direct and indirect effects of uts2b perturbation on developmental processes.

What methodologies are most effective for analyzing differential gene expression in response to uts2b perturbation?

When analyzing differential gene expression in response to uts2b perturbation, researchers should implement the following methodological framework:

  • Experimental Design Considerations:

    • Include biological replicates (minimum n=3) to account for natural variation

    • Control for batch effects in sequencing and sample preparation

    • Consider cell type-specific effects using single-cell approaches

    • Include time-course experiments to capture dynamic responses

  • Statistical Analysis Approach:

    • Apply rigorous statistical tests (e.g., Wilcoxon signed-rank test) to identify differentially expressed genes (DEGs)

    • Set appropriate cutoffs based on adjusted p-values and fold change

    • Verify consistency across biological replicates to ensure reliability

    • Account for technical noise inherent in expression measurements

  • Data Integration Strategies:

    • Leverage knowledge graphs to contextualize findings

    • Compare results across different cell lines or developmental stages

    • Integrate with protein-protein interaction networks

  • Validation Methods:

    • Confirm key findings with qRT-PCR

    • Perform protein-level validation via Western blotting

    • Use in situ hybridization to verify spatial expression patterns

This comprehensive approach allows for robust identification of genes affected by uts2b perturbation, distinguishing between direct targets and secondary effects . Given that individual gene measurements may be unreliable due to biological and technical noise, statistical analyses at the pathway or gene set level are often more informative for biological interpretation.

How can computational models predict the effects of uts2b mutations on protein function?

Computational modeling of uts2b mutations involves a multi-tiered approach:

  • Structural Modeling:

    • Generate 3D protein structure using homology modeling or AlphaFold2 predictions

    • Implement molecular dynamics simulations to assess structural stability

    • Perform in silico mutagenesis to predict effects on protein folding

  • Sequence-Based Predictions:

    • Identify conserved residues through multiple sequence alignment

    • Apply SIFT, PolyPhen, or PROVEAN algorithms to predict mutation impacts

    • Calculate evolutionary conservation scores to prioritize functionally important residues

  • Interaction Network Analysis:

    • Model protein-protein interactions affected by mutations

    • Predict alterations in binding affinity to receptors

    • Simulate downstream signaling pathway perturbations

  • Integrative Approach:

    • Combine structural, sequence, and network predictions

    • Validate computational predictions with experimental data

    • Refine models iteratively based on experimental feedback

This computational framework provides testable hypotheses about mutation effects that can guide experimental design, particularly for site-directed mutagenesis studies aimed at understanding structure-function relationships in uts2b . The integration of multiple computational approaches increases prediction accuracy and biological relevance.

What approaches can effectively differentiate between uts2a and uts2b paralog functions in zebrafish?

Differentiating between the functions of uts2a and uts2b paralogs requires complementary experimental strategies:

  • Paralog-Specific Genetic Perturbations:

    • Generate single and double knockout lines (uts2a-/-, uts2b-/-, uts2a-/-;uts2b-/-)

    • Design paralog-specific morpholinos targeting unique sequence regions

    • Create rescue constructs expressing only one paralog

  • Expression Pattern Analysis:

    • Perform dual-color in situ hybridization to visualize co-expression or distinct expression domains

    • Generate transgenic reporter lines (uts2a:GFP, uts2b:RFP) to track expression dynamics

    • Quantify relative expression levels across developmental stages and tissues

  • Functional Complementation Tests:

    • Cross-rescue experiments (can uts2a rescue uts2b phenotypes and vice versa?)

    • Domain-swapping experiments to identify functionally distinct protein regions

    • Receptor binding assays to determine ligand specificity

  • Transcriptomic Profiling:

    • Compare transcriptional responses to individual paralog perturbations

    • Identify unique and shared downstream targets

    • Perform gene set enrichment analysis to determine pathway specificity

This multi-faceted approach enables researchers to delineate the distinct biological roles of these paralogs, providing insights into the evolutionary divergence of gene function following duplication events . The comparison between paralogs can reveal fundamental principles of protein evolution and functional specialization.

How can contradictory results in uts2b signaling pathway analysis be reconciled and interpreted?

Reconciling contradictory results in uts2b signaling requires systematic troubleshooting and contextual interpretation:

  • Sources of Experimental Variation:

    • Cell line or developmental stage differences may explain divergent results

    • Experimental conditions (temperature, medium composition) can influence signaling outcomes

    • Genetic background effects may modulate uts2b signaling

  • Methodological Reconciliation Approach:

    • Standardize experimental protocols across research groups

    • Implement meta-analysis of multiple datasets using consistent statistical methods

    • Develop consensus reporting standards for uts2b experiments

  • Biological Interpretation Framework:

    • Consider context-dependent signaling (cell type, developmental timing)

    • Evaluate compensatory mechanisms activated in different experimental systems

    • Assess potential cross-talk with other signaling pathways

  • Resolution Strategies:

    • Design definitive experiments addressing specific contradictions

    • Use orthogonal methodologies to validate key findings

    • Implement systems biology approaches to model complex pathway interactions

This structured approach transforms apparent contradictions into opportunities for deeper understanding of context-dependent signaling mechanisms . When analyzing conflicting data, researchers should consider both the technical aspects (experimental design, statistical power) and biological factors (compensatory mechanisms, cellular context) that might explain the observed differences.

What are the optimal positive and negative controls for uts2b functional assays?

Designing rigorous controls for uts2b functional assays is critical for experimental validity:

Control TypeRecommended ControlsRationaleLimitations
Negative ControlsHeat-inactivated uts2bTests activity dependence on protein structureMay not control for contaminants
Buffer-only treatmentControls for vehicle effectsDoes not account for non-specific protein effects
Scrambled peptide with same amino acid compositionControls for amino acid-specific effectsMay have unexpected bioactivity
Positive ControlsCommercial urotensin II peptideKnown bioactivity benchmarkMay differ from full-length protein effects
uts2a paralog (for comparative studies)Evaluates paralog-specific functionsDifferent potency may complicate interpretation
Specificity Controlsuts2b pre-incubated with neutralizing antibodyConfirms signal is uts2b-dependentAntibody may have incomplete neutralization
Receptor antagonist co-treatmentValidates receptor-mediated effectsMay have off-target effects

These controls should be systematically included in experimental designs to enable confident interpretation of results . The selection of appropriate controls depends on the specific research question and experimental system, with particular attention to potential confounding factors.

How can the cleaved forms of uts2b be separated and studied individually?

The separation and individual study of cleaved uts2b forms requires specialized techniques:

  • Separation Methods:

    • High-Performance Liquid Chromatography (HPLC) with specific columns optimized for peptide separation

    • Size Exclusion Chromatography (SEC) to separate based on molecular size differences

    • Immunoaffinity purification using form-specific antibodies

    • Electrophoretic techniques optimized for small peptides

  • Verification Approaches:

    • Mass spectrometry to confirm identity and purity

    • N-terminal sequencing to verify correct processing

    • Western blotting with form-specific antibodies

    • Circular dichroism to assess secondary structure

  • Individual Form Expression:

    • Synthetic peptide production for the mature Urotensin II-beta

    • Recombinant expression of truncated constructs

    • Site-directed mutagenesis to prevent cleavage for studying Urophysin beta

  • Functional Characterization:

    • Receptor binding assays for individual forms

    • Signaling pathway activation comparison

    • Physiological response measurement (vasoconstriction, calcium flux)

This methodological approach enables researchers to dissect the potentially distinct functions of the cleaved products from the uts2b precursor . Separate characterization of these forms is particularly important since post-translational processing can dramatically alter bioactivity and receptor specificity.

How should uts2b perturbation data be integrated with other -omics datasets?

Integration of uts2b perturbation data with other -omics datasets requires a structured analytical framework:

  • Multi-omics Data Integration Workflow:

    • Normalize data across platforms to enable direct comparisons

    • Implement dimensionality reduction techniques (PCA, t-SNE) to visualize relationships

    • Apply computational methods that account for different data types:

      • Network-based integration (weighted correlation networks)

      • Bayesian integration methods

      • Multi-block statistical approaches

  • Biological Knowledge Integration:

    • Map data to biological pathways using databases like Reactome

    • Leverage Gene Ontology annotations to identify functional enrichment

    • Incorporate protein-protein interaction networks from databases like STRING

  • Temporal and Spatial Integration:

    • Align developmental timepoints across datasets

    • Consider tissue/cell type-specific effects

    • Track dynamic changes in response to perturbation

  • Visualization Strategies:

    • Create integrative heatmaps showing patterns across datasets

    • Develop network visualizations highlighting key interactions

    • Implement interactive dashboards for data exploration

This integrative approach reveals emergent properties not evident in individual datasets, providing a systems-level understanding of uts2b function . When integrating datasets from different sources, careful attention must be paid to batch effects, technical variability, and differences in experimental design that might influence interpretation.

What statistical approaches best account for biological variability in uts2b expression studies?

Managing biological variability in uts2b expression studies requires sophisticated statistical approaches:

  • Variance Component Analysis:

    • Quantify sources of variability (biological vs. technical)

    • Implement mixed-effects models to account for nested experimental designs

    • Calculate intraclass correlation coefficients to assess reliability

  • Robust Statistical Methods:

    • Apply non-parametric tests (e.g., Wilcoxon signed-rank test) when assumptions of normality are violated

    • Implement bootstrap resampling to estimate confidence intervals

    • Use permutation tests for hypothesis testing with small sample sizes

  • Bayesian Approaches:

    • Incorporate prior knowledge to improve inference

    • Implement hierarchical models to share information across related conditions

    • Calculate posterior probabilities for more nuanced interpretations

  • Multiple Testing Correction:

    • Apply appropriate correction methods (Benjamini-Hochberg, Bonferroni) for large-scale analyses

    • Implement q-value approaches to control false discovery rate

    • Consider the trade-off between Type I and Type II errors based on experimental goals

These statistical approaches improve the reliability and reproducibility of uts2b expression studies by properly accounting for the inherent biological variability present in living systems . The selection of appropriate statistical methods should be guided by the experimental design, sample size, and specific research questions being addressed.

How can zebrafish uts2b research inform studies of human urotensin II-related disorders?

Zebrafish uts2b research provides valuable translational insights through comparative approaches:

  • Cross-Species Comparative Analysis:

    • Identify conserved structural and functional domains between zebrafish uts2b and human urotensin II

    • Map zebrafish phenotypes to potential human disease manifestations

    • Compare receptor binding profiles and signaling pathway activation

  • Disease Modeling Approaches:

    • Generate zebrafish models mimicking human urotensin II system mutations

    • Validate phenotypes against known human pathologies (cardiovascular, metabolic, renal)

    • Perform high-throughput drug screening using zebrafish disease models

  • Mechanistic Insights Translation:

    • Determine if molecular mechanisms identified in zebrafish are conserved in human systems

    • Correlate gene expression patterns across species to identify conserved regulatory networks

    • Validate key findings in human cell lines or tissues

  • Therapeutic Development Pipeline:

    • Use zebrafish for initial screening of urotensin II pathway modulators

    • Identify potential biomarkers for human disease progression

    • Develop targeted therapeutic approaches based on conserved signaling nodes

This translational approach leverages the experimental advantages of zebrafish while maintaining focus on human health applications . When designing translational studies, researchers should critically evaluate both the similarities and differences between zebrafish and human systems to ensure appropriate interpretation of results.

What methodological adaptations are needed when transitioning from uts2b studies in zebrafish to mammalian models?

Transitioning from zebrafish to mammalian models requires methodological adaptations:

  • Experimental Design Modifications:

    • Adjust developmental timeframes to account for species differences

    • Consider the absence of paralogs in mammalian systems (single UTS2 gene)

    • Adapt tissue collection and processing protocols for larger organisms

    • Implement tissue-specific conditional approaches for targeted studies

  • Analytical Considerations:

    • Recalibrate expression analysis parameters for mammalian reference genomes

    • Adjust statistical power calculations based on increased biological variability

    • Consider species-specific post-translational modifications and processing

  • Translation Validation Framework:

    • Parallel testing in both zebrafish and mammalian systems

    • Confirmation of key molecular interactions in mammalian cells

    • Cross-validation of phenotypes across model systems

    • Verification of drug responses in both zebrafish and mammalian models

  • Methodological Limitations to Consider:

    • Differences in bioavailability and pharmacokinetics between species

    • Variations in receptor distribution and density

    • Divergent physiological responses due to anatomical differences

    • Species-specific compensatory mechanisms

This structured transition approach ensures that insights gained from zebrafish studies are appropriately translated to mammalian systems, accounting for evolutionary divergence while leveraging conserved biology . Researchers should implement targeted validation experiments to confirm that mechanisms identified in zebrafish are conserved in mammalian models before proceeding to potential clinical applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.